跳至主要内容
临床试验/CTRI/2022/09/046026
CTRI/2022/09/046026尚未招募不适用

“Analyzing selected health-related parameters and illness experiences of patients with Acute Myeloid Leukemia and their caretakersâ€.

Dr R Shankar Shanmugam1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2022年1月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
100
试验地点
1
主要终点
we can able get information about sleeplessness, drug adherence ,functional ability, stress, resilience and social support status of Acute myeloid Leukemic patients and illness experience of their Care takers.

研究概览

简要总结

The study will be started from  01-10-2022

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • Adults diagnosed with Leukemia and on treatment for more than six months
  • Able to understand & speak Tamil.
  • Leukemia adults who are stable.

排除标准

  • Not able to speak Tamil Not willing to participate With complications.

结局指标

主要结局

we can able get information about sleeplessness, drug adherence ,functional ability, stress, resilience and social support status of Acute myeloid Leukemic patients and illness experience of their Care takers.

时间窗: only baseline information will be collected at a single time point

次要结局

  • The secondary outcome will be(about Financial burden,Self Efficacy,Quality of life and the Illness experience of the Acute Myeloid leukemia patients.)

研究者

发起方
Dr R Shankar Shanmugam
申办方类型
Other [self]

研究点 (1)

Loading locations...

相似试验